Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors.

•Two novel series of conformationally constrained BET inhibitors have been prepared and characterized.•Compounds in each series demonstrate single digit nanomolar potency in binding and cellular assays.•Compounds in each series show inhibition of tumor growth in a mouse xenograft model.